longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Stryker

SYK

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 28.08, below the reasonable range, cheaper than 99.69% of the time in the past 5 years, and the industry ranks 28/174, the industry Median -0.89.

28.08xP/E
$272.96Stock price
$9.72Earnings per share
28.08xP/E
Stock price$272.96Earnings per share$9.72

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
41.41x
Typical range
37.78x–48.42x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
21.14x26.89%$110.57B
SYKUSStryker
28.08x53.09%$104.70B
BSXUSBoston Scientific
17.05x36.31%$62.65B
RMDUSResmed
20.94x11.53%$31.90B
PHGUSKoninklijke Philips Elect
18.00x16.23%$23.27B
RYLPFUSKoninklijke Philips N.V.
18.41x--$23.81B
TRUMYUSTerumo
20.66x--$21.71B
STEUSSteris
25.35x17.10%$20.41B
ZBHUSZimmer Biomet
20.82x37.01%$16.80B
SNNUSSmith and Nephew
17.61x42.74%$11.18B
GMEDUSGlobus Medical Inc
18.66x6.02%$9.99B
PODDUSInsulet
24.17x76.03%$9.07B
SSMXYUSSysmex
28.16x--$7.12B
LIVNUSLivanova
21.83x189.82%$4.12B
TMDXUSTransMedics
17.98x71.90%$2.73B
INSPUSInspire Medical
15.15x100.86%$2.05B
LMATUSLemaitre Vascular
27.90x13.99%$1.83B
CNMDUSConmed
24.35x156.95%$1.38B
TCMDUSTactile
19.78x36.59%$491.78M
BWAYUSBrainsway
26.14x70.37%$246.78M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.